Long progression-free survival with cabozantinib in a heavily pretreated patient with metastatic renal cell carcinoma: a case report.
Tumori
; 107(6): NP33-NP36, 2021 Dec.
Article
in En
| MEDLINE
| ID: mdl-33526000
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyridines
/
Carcinoma, Renal Cell
/
Kidney Neoplasms
/
Anilides
Type of study:
Prognostic_studies
Limits:
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Tumori
Year:
2021
Document type:
Article
Affiliation country:
Italia
Country of publication:
Estados Unidos